Paolo Mazzeo

10PUBLICATIONS
52CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 19, 2025
Clonal evolution and apoptosis resistance in myelodysplastic neoplasms and acute myeloid leukemia under treatment: insights from integrative longitudinal profiling.

Paolo Mazzeo, Sarah Mae Penir, Evgenii Shumilov

|Aug 04, 2025
Discovery of molecularly-informed therapeutic strategies for mature T-cell leukemias and lymphomas.

Nicole Schmidt, Kevin Kornrumpf, Lena Ries

|Apr 16, 2025
Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma.

Evgenii Shumilov, Julia Katharina Scholz, Maximilian Seib

|Dec 11, 2024
Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study.

Evgenii Shumilov, Rebecca Wurm-Kuczera, Andrea Kerkhoff

|Dec 11, 2024
Allogeneic stem cell transplantation against aggressive lymphomas: graft-versus-lymphoma effects in peripheral T-cell lymphoma and diffuse large B-cell lymphoma after myeloablative conditioning.

Evgenii Shumilov, Lena Levien, Paolo Mazzeo

|Sep 24, 2024
Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real-world cohort of patients with lower-risk MDS.

Paolo Mazzeo, Christina Ganster, John Wiedenhöft

Pageof 2

Frequent Collaborators

4 joint publications

Evgenii Shumilov

3 joint publications

Thomas Pabst

3 joint publications

Ulrike Bacher

3 joint publications

Björn Chapuy